ARCHIVES

Oncotype DX Cancer Test Can Predict Recurrence

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: san Antonio’s ICRC Gets a New Name, SACI; Blum Is deputy Oncology Director At Kaplan

May 14, 1993

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001

NCCS Appointment Marks Transition To New Structure.

March 17, 2000

NIH reauthorization to be topic of July 19 hearing.

July 15, 2005

Mesothelioma Survival, QOL Improved With Alimta, Platinol

March 28, 2003

Cancer Control Progress, Challenge Mark ACS Observance

October 18, 1991